238 related articles for article (PubMed ID: 31082632)
1. Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma.
Tabrizi S; Yeap BY; Sherman JC; Nachtigall LB; Colvin MK; Dworkin M; Fullerton BC; Daartz J; Royce TJ; Oh KS; Batchelor TT; Curry WT; Loeffler JS; Shih HA
Radiother Oncol; 2019 Aug; 137():95-101. PubMed ID: 31082632
[TBL] [Abstract][Full Text] [Related]
2. Proton therapy for low-grade gliomas: Results from a prospective trial.
Shih HA; Sherman JC; Nachtigall LB; Colvin MK; Fullerton BC; Daartz J; Winrich BK; Batchelor TT; Thornton LT; Mancuso SM; Saums MK; Oh KS; Curry WT; Loeffler JS; Yeap BY
Cancer; 2015 May; 121(10):1712-9. PubMed ID: 25585890
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine late effects after tailored photon radiotherapy for children with low grade gliomas: Long term correlation with tumour and treatment parameters.
Aloi D; Belgioia L; Barra S; Giannelli F; Cavagnetto F; Gallo F; Milanaccio C; Garrè M; Di Profio S; Di Iorgi N; Corvò R
Radiother Oncol; 2017 Nov; 125(2):241-247. PubMed ID: 29037775
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas.
Greenberger BA; Pulsifer MB; Ebb DH; MacDonald SM; Jones RM; Butler WE; Huang MS; Marcus KJ; Oberg JA; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1060-1068. PubMed ID: 25035209
[TBL] [Abstract][Full Text] [Related]
5. Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma.
Indelicato DJ; Rotondo RL; Uezono H; Sandler ES; Aldana PR; Ranalli NJ; Beier AD; Morris CG; Bradley JA
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):149-156. PubMed ID: 30684665
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy.
Ludmir EB; Mahajan A; Paulino AC; Jones JY; Ketonen LM; Su JM; Grosshans DR; McAleer MF; McGovern SL; Lassen-Ramshad YA; Adesina AM; Dauser RC; Weinberg JS; Chintagumpala MM
Neuro Oncol; 2019 May; 21(5):686-695. PubMed ID: 30753704
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma.
Harrabi SB; Bougatf N; Mohr A; Haberer T; Herfarth K; Combs SE; Debus J; Adeberg S
Strahlenther Onkol; 2016 Nov; 192(11):759-769. PubMed ID: 27363701
[TBL] [Abstract][Full Text] [Related]
8. Sequential proton boost after standard chemoradiation for high-grade glioma.
Adeberg S; Bernhardt D; Harrabi SB; Uhl M; Paul A; Bougatf N; Verma V; Unterberg A; Wick W; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
Radiother Oncol; 2017 Nov; 125(2):266-272. PubMed ID: 29050959
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Failure Among Patients With Low-grade Glioma Treated With Proton Radiation Therapy.
Kamran SC; Dworkin M; Niemierko A; Bussiere M; Oh KS; Loeffler JS; Shih HA
Pract Radiat Oncol; 2019; 9(4):e356-e361. PubMed ID: 30790717
[TBL] [Abstract][Full Text] [Related]
10. First experiences in treatment of low-grade glioma grade I and II with proton therapy.
Hauswald H; Rieken S; Ecker S; Kessel KA; Herfarth K; Debus J; Combs SE
Radiat Oncol; 2012 Nov; 7():189. PubMed ID: 23140402
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced contrast enhancement following proton radiotherapy for low-grade glioma depends on tumor characteristics and is rarer in children than adults.
Eichkorn T; Bauer J; Bahn E; Lischalk JW; Meixner E; Sandrini E; Regnery S; Held T; Hörner-Rieber J; Alber M; Herfarth K; Debus J; König L; Harrabi S
Radiother Oncol; 2022 Jul; 172():54-64. PubMed ID: 35568281
[TBL] [Abstract][Full Text] [Related]
12. Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma - How safe are protons?
Harrabi SB; von Nettelbladt B; Gudden C; Adeberg S; Seidensaal K; Bauer J; Bahn E; Mairani A; Alber M; Haberer T; Debus J; Herfarth K
Radiother Oncol; 2022 Feb; 167():211-218. PubMed ID: 34973277
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1
Kondo N; Barth RF; Miyatake SI; Kawabata S; Suzuki M; Ono K; Lehman NL
J Neurooncol; 2017 May; 133(1):107-118. PubMed ID: 28534152
[TBL] [Abstract][Full Text] [Related]
14. Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide.
Dworkin M; Mehan W; Niemierko A; Kamran SC; Lamba N; Dietrich J; Martinez-Lage M; Oh KS; Batchelor TT; Wen PY; Loeffler JS; Shih HA
J Neurooncol; 2019 Mar; 142(1):69-77. PubMed ID: 30488294
[TBL] [Abstract][Full Text] [Related]
15. Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy.
van West SE; de Bruin HG; van de Langerijt B; Swaak-Kragten AT; van den Bent MJ; Taal W
Neuro Oncol; 2017 May; 19(5):719-725. PubMed ID: 28453748
[TBL] [Abstract][Full Text] [Related]
16. Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial.
Fitzek MM; Thornton AF; Harsh G; Rabinov JD; Munzenrider JE; Lev M; Ancukiewicz M; Bussiere M; Hedley-Whyte ET; Hochberg FH; Pardo FS
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):131-7. PubMed ID: 11516862
[TBL] [Abstract][Full Text] [Related]
17. Treatment burden and long-term health deficits of patients with low-grade gliomas or glioneuronal tumors diagnosed during the first year of life.
Liu APY; Hastings C; Wu S; Bass JK; Heitzer AM; Ashford J; Vestal R; Hoehn ME; Ghazwani Y; Acharya S; Conklin HM; Boop F; Merchant TE; Gajjar A; Qaddoumi I
Cancer; 2019 Apr; 125(7):1163-1175. PubMed ID: 30620400
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.
Adeberg S; Harrabi SB; Bougatf N; Bernhardt D; Rieber J; Koerber SA; Syed M; Sprave T; Mohr A; Abdollahi A; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
Strahlenther Onkol; 2016 Nov; 192(11):770-779. PubMed ID: 27334276
[TBL] [Abstract][Full Text] [Related]
19. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.
Douw L; Klein M; Fagel SS; van den Heuvel J; Taphoorn MJ; Aaronson NK; Postma TJ; Vandertop WP; Mooij JJ; Boerman RH; Beute GN; Sluimer JD; Slotman BJ; Reijneveld JC; Heimans JJ
Lancet Neurol; 2009 Sep; 8(9):810-8. PubMed ID: 19665931
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.
Wahl M; Phillips JJ; Molinaro AM; Lin Y; Perry A; Haas-Kogan DA; Costello JF; Dayal M; Butowski N; Clarke JL; Prados M; Nelson S; Berger MS; Chang SM
Neuro Oncol; 2017 Feb; 19(2):242-251. PubMed ID: 27571885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
